PT141 10MG

PT‑141 (Bremelanotide)
A melanocortin receptor agonist that directly activates MC3/MC4 receptors in the brain to enhance sexual arousal (libido), independently of vascular mechanisms. FDA‑approved as Bremelanotide for hypoactive sexual desire disorder in premenopausal women. Works within hours post-administration, but may cause nausea and increased blood pressure in some users.

References

Kingsberg, S. A., Clayton, A. H., Portman, D., DeRogatis, L. R., & Krop, J. (2019). Bremelanotide for the treatment of hypoactive sexual desire disorder. Obstetrics and Gynecology, 134(5), 878–887. https://doi.org/10.1097/AOG.0000000000003537

Original price was: $39.99.Current price is: $19.99.

Availability: 6 in stock

Related Products

Scroll to Top